Advanced Search
Your search returned 125 results
  • Nov 20, 2014
    New device is the only commercially available bedside monitor designed for home care and sleep study settings

    DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 20, 2014-- Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO2 Patient Monitoring System, PM100N. The system currently is...

  • Nov 18, 2014
    Revenue of $4.4 Billion Grew 5% on Constant Currency Basis; 4% as Reported

    MINNEAPOLIS - Nov. 18, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2015, which ended October 24, 2014. The company reported worldwide...

  • Nov 5, 2014
    Fourth-quarter net sales up 7%; Medical Devices sales up 8%

    DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 5, 2014-- Covidien plc (NYSE: COV) today announced financial results for the fourth quarter of fiscal 2014. Fourth-quarter net sales of $2.73 billion...

  • Oct 9, 2014
    Monitor is only portable oximeter on the market that is indicated for use in home care settings and is compliant with international standards for devices used in the home health care environment

    DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 9, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for the Nellcor™ Portable SpO2 Patient Monitoring...

  • Sep 17, 2014

    DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 17, 2014-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a 13% increase in the quarterly dividend rate, from $0.32 per...